scholarly journals A discontinuous Galerkin model for fluorescence loss in photobleaching of intracellular polyglutamine protein aggregates

2018 ◽  
Author(s):  
Christian Valdemar Hansen ◽  
Hans J Schroll ◽  
Daniel Wüstner

Background: Intracellular phase separation and aggregation of proteins with extended poly-glutamine (polyQ) stretches are hallmarks of various age-associated neurodegenerative diseases. Progress in our understanding of such processes heavily relies on quantitative fluorescence imaging of suitably tagged proteins. Fluorescence loss in photobleaching (FLIP) is particularly well-suited to study the dynamics of protein aggregation in cellular models of Chorea Huntington and other polyQ diseases, as FLIP gives access to the full spatio-temporal profile of intensity changes in the cell geometry. In contrast to other methods, also dim aggregates become visible during time evolution of fluorescence loss in cellular compartments. However, methods for computational analysis of FLIP data are sparse, and transport models for estimation of transport and diffusion parameters from experimental FLIP sequences are missing. Results: In this paper, we present a computational method for analysis of FLIP imaging experiments of intracellular polyglutamine protein aggregates also called inclusion bodies (IBs). By this method, we are able to determine the diffusion constant and nuclear membrane permeability coefficients of polyQ proteins as well as the exchange rates between aggregates and the cytoplasm. Our method is based on a reaction-diffusion multi-compartment model defined on a mesh obtained by segmentation of the cell images from the FLIP sequence. The discontinuous Galerkin (DG) method is used for numerical implementation of our model in FEniCS, which greatly reduces the computing time. The method is applied to representative experimental FLIP sequences, and consistent estimates of all transport parameters are obtained. Conclusions: By directly estimating the transport parameters from live-cell image sequences using our new computational FLIP approach surprisingly fast exchange dynamics of mutant Huntingtin between cytoplasm and dim IBs could be revealed. This is likely relevant also for other polyQ diseases. Thus, our method allows for quantifying protein dynamics at different stages of the protein aggregation process in cellular models of neurodegeneration.

2008 ◽  
Vol 283 (12) ◽  
pp. 7648-7656 ◽  
Author(s):  
Amit Mishra ◽  
Priyanka Dikshit ◽  
Sudarshana Purkayastha ◽  
Jaiprakash Sharma ◽  
Nobuyuki Nukina ◽  
...  

2000 ◽  
Vol 275 (14) ◽  
pp. 10437-10442 ◽  
Author(s):  
Yoshitaka Nagai ◽  
Timothy Tucker ◽  
Hongzu Ren ◽  
Daniel J. Kenan ◽  
Barry S. Henderson ◽  
...  

2015 ◽  
Vol 35 (10) ◽  
pp. 1754-1762 ◽  
Author(s):  
Sangjune Kim ◽  
Dohyun Lee ◽  
Juhyun Lee ◽  
Haengjin Song ◽  
Hyo-Jin Kim ◽  
...  

Molecular chaperones monitor the proper folding of misfolded proteins and function as the first line of defense against mutant protein aggregation in neurodegenerative diseases. The eukaryotic chaperonin TRiC is a potent suppressor of mutant protein aggregation and toxicity in early stages of disease progression. Elucidation of TRiC functional regulation will enable us to better understand the pathological mechanisms of neurodegeneration. We have previously shown that vaccinia-related kinase 2 (VRK2) downregulates TRiC protein levels through the ubiquitin-proteasome system by recruiting the E3 ligase COP1. However, although VRK2 activity was necessary in TRiC downregulation, the phosphorylated substrate was not determined. Here, we report that USP25 is a novel TRiC interacting protein that is also phosphorylated by VRK2. USP25 catalyzed deubiquitination of the TRiC protein and stabilized the chaperonin, thereby reducing accumulation of misfolded polyglutamine protein aggregates. Notably, USP25 deubiquitinating activity was suppressed when VRK2 phosphorylated the Thr680, Thr727, and Ser745residues. Impaired USP25 deubiquitinating activity after VRK2-mediated phosphorylation may be a critical pathway in TRiC protein destabilization.


2006 ◽  
Vol 2006 ◽  
pp. 1-5 ◽  
Author(s):  
J. Avila ◽  
I. Santa-María ◽  
M. Pérez ◽  
F. Hernández ◽  
F. Moreno

Protein aggregation takes place in many neurodegenerative disorders. However, there is a controversy about the possible toxicity of these protein aggregates. In this review, this controversy is discussed, focussing on the tau aggregation that takes place in those disorders known as tauopathies.


Sign in / Sign up

Export Citation Format

Share Document